Arkolith/Insider Trading/ABOS/Form 4

Porter Derrell

DirectorAcumen Pharmaceuticals, Inc. (ABOS) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$75K
Net Open-Market Flow
-$75K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)13K$1.07$14K49K
Jun 17, 2026Sell(S)13K$2.33$30K36K
Jun 16, 2026Sell(S)13K$2.33$30K36K
Jun 15, 2026Option exercise(M)6K$1.07$7K55K
Jun 15, 2026Sell(S)6K$2.35$15K48K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)13K—$00
Jun 15, 2026Option exercise(M)6K—$013K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-043987) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML